AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25534294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib plus docetaxel
Number of subjects: 0
Study 25534294 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 0
Study 25534294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0
Study 23412024 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based psychoeducation program
Number of subjects: 96
Study 23412024 — intervention group
Group type: COMPARATOR
Intervention: Usual psychiatric care
Number of subjects: 96
Study 21421952 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to Above the Influence antidrug advertisements
Number of subjects: 0
Study 19120074 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral therapy (Ganciclovir and valganciclovir) for 3 weeks
Number of subjects: 256
Study 19120074 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral therapy (Ganciclovir and valganciclovir)
Number of subjects: 256
Study 19120074 — intervention group
Group type: EXPERIMENTAL
Intervention: HHV‐6 co-infection
Number of subjects: 256
Study 19120074 — intervention group
Group type: EXPERIMENTAL
Intervention: HHV‐7 co-infection
Number of subjects: 256
Study 17805109 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative topical Sensorcaine
Number of subjects: 37
Study 17805109 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 37
Study 14754739 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoPearl adjunct to bioabsorbable interference screw fixation
Number of subjects: 35
Study 14754739 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 35
Study 12452980 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (FK506)
Number of subjects: 79
Study 12452980 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin
Number of subjects: 79
Study 12452980 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin plus Nifedipine
Number of subjects: 79
Study 10999089 — intervention group
Group type: EXPERIMENTAL
Intervention: benidipine 4 mg/day
Number of subjects: 34
Study 10999089 — intervention group
Group type: EXPERIMENTAL
Intervention: benidipine 8 mg/day
Number of subjects: 34
Study 10999089 — intervention group
Group type: EXPERIMENTAL
Intervention: benidipine 4-8 mg/day
Number of subjects: 34
Study 7482166 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic mesh hernia repair
Number of subjects: 34
Study 7482166 — intervention group
Group type: EXPERIMENTAL
Intervention: Open mesh hernia repair
Number of subjects: 34
Study 7482166 — intervention group
Group type: EXPERIMENTAL
Intervention: Bassini repair
Number of subjects: 34
Study 2271468 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 44
Study 2271468 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 44
Study 7007454 — intervention group
Group type: COMPARATOR
Intervention: 5 mg folate tablets (Group B)
Number of subjects: 30
Study 7007454 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate mouthwash (Group C)
Number of subjects: 30
Study 7007454 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash and tablets (Group A)
Number of subjects: 30
Study 7007454 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash and 5 mg folate tablets (Group B)
Number of subjects: 30
Study 31796533 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy in addition to inguinofemoral lymphadenectomy
Number of subjects: 80
Study 31796533 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 80
Study 31152118 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 48
Study 31152118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 28759302 — intervention group
Group type: EXPERIMENTAL
Intervention: Clacier™ (0.05% CsA nanoemulsion)
Number of subjects: 0
Study 28759302 — intervention group
Group type: COMPARATOR
Intervention: Restasis® (conventional emulsion)
Number of subjects: 0
Study 26053853 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-salt diet (LSD)
Number of subjects: 180
Study 26053853 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg/HCTZ 12.5 mg (NLSD)
Number of subjects: 180
Study 26053853 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan 150 mg/HCTZ 12.5 mg (NLSD)
Number of subjects: 180
Study 26053853 — intervention group
Group type: COMPARATOR
Intervention: Losartan 100 mg (NLSD)
Number of subjects: 180
Study 23400982 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-guided anesthesia (maintaining BIS value of 40 to 60)
Number of subjects: 723
Study 23400982 — intervention group
Group type: COMPARATOR
Intervention: ETAC-guided anesthesia (age-adjusted minimum alveolar concentration of 0.7 to 1.3)
Number of subjects: 723
Study 21625788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling according to nutritional status
Number of subjects: 315
Study 21625788 — intervention group
Group type: COMPARATOR
Intervention: Routine of the health service facility (Control Group)
Number of subjects: 315
Study 19207096 — intervention group
Group type: EXPERIMENTAL
Intervention: Prulifloxacin
Number of subjects: 0
Study 17445815 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 46
Study 17445815 — intervention group
Group type: COMPARATOR
Intervention: Operative treatment
Number of subjects: 46
Study 15558635 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood induction (failure on a quiz)
Number of subjects: 0
Study 15558635 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 0
Study 15558635 — intervention group
Group type: EXPERIMENTAL
Intervention: High impulsivity
Number of subjects: 0
Study 15558635 — intervention group
Group type: EXPERIMENTAL
Intervention: Low impulsivity
Number of subjects: 0
Study 11447365 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) supplementation
Number of subjects: 8
Study 11447365 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 8
Study 9065680 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 367
Study 9065680 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 367
Study 9065680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study 8419896 — intervention group
Group type: EXPERIMENTAL
Intervention: Left lateral positioning
Number of subjects: 16
Study 8419896 — intervention group
Group type: EXPERIMENTAL
Intervention: Right lateral positioning
Number of subjects: 16
Study 8419896 — intervention group
Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 16
Study 3094439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 0.25 g single dose
Number of subjects: 100
Study 3094439 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin 3.5 g plus probenecid 1.0 g
Number of subjects: 100
Study 3094439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 100
Study 3094439 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin plus probenecid
Number of subjects: 100
Study 31223624 — intervention group
Group type: EXPERIMENTAL
Intervention: General public awareness of prescription drugs
Number of subjects: 1000
Study 31223624 — intervention group
Group type: EXPERIMENTAL
Intervention: General public awareness of antibiotic use
Number of subjects: 1000
Study 31223624 — intervention group
Group type: EXPERIMENTAL
Intervention: General public awareness of antibiotic resistance (AR)
Number of subjects: 1000
Study 31223624 — intervention group
Group type: COMPARATOR
Intervention: Awareness of prescription medicine by gender
Number of subjects: 1000
Study 31223624 — intervention group
Group type: COMPARATOR
Intervention: Awareness of antibiotic resistance by occupation
Number of subjects: 1000
Study 31223624 — intervention group
Group type: COMPARATOR
Intervention: Awareness of prescription medicine by ethnicity
Number of subjects: 1000
Study 28750585 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 g/kg β‐OHB ketone salts
Number of subjects: 10
Study 28750585 — intervention group
Group type: COMPARATOR
Intervention: Flavour‐matched placebo
Number of subjects: 10
Study 26055122 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive control training targeting working memory functioning (10 online sessions over 14 days)
Number of subjects: 0
Study 26055122 — intervention group
Group type: COMPARATOR
Intervention: Low cognitive load training (active control condition)
Number of subjects: 0
Study 26055122 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive control training
Number of subjects: 0
Study 22856682 — intervention group
Group type: EXPERIMENTAL
Intervention: Air particle abrasion for five seconds with 50-μm aluminum oxide particles (Groups 1-3)
Number of subjects: 18
Study 22856682 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid etching with 10% hydrofluoric acid for 20 seconds (Groups 4-6)
Number of subjects: 18
Study 22856682 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific treatment mentioned)
Number of subjects: 18
Study 21127866 — intervention group
Group type: EXPERIMENTAL
Intervention: a‐PVAM (700‐900‐μm)
Number of subjects: 46
Study 21127866 — intervention group
Group type: COMPARATOR
Intervention: TAGM (500‐700‐μm)
Number of subjects: 46
Study 19151046 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (100-4000 microg)
Number of subjects: 645
Study 17716364 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, standardized and comprehensive complex intervention including patient leaflets, documentation booklets, regular monitoring by a trained practice nurse, and tailored structured counselling by GPs.
Number of subjects: 0
Study 17716364 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, standardized and comprehensive complex intervention.
Number of subjects: 0
Study 17716364 — intervention group
Group type: COMPARATOR
Intervention: Usual care by GPs with guideline-oriented management and tailored health counselling concept.
Number of subjects: 0
Study 15184095 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental arithmetic with harassment followed by cold pressor (MA/CP)
Number of subjects: 53
Study 15184095 — intervention group
Group type: COMPARATOR
Intervention: Cold pressor followed by mental arithmetic (CP/MA)
Number of subjects: 53
Study 11125190 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunnel preparation
Number of subjects: 60
Study 11125190 — intervention group
Group type: COMPARATOR
Intervention: Class II cavity preparation
Number of subjects: 60
Study 9329638 — intervention group
Group type: EXPERIMENTAL
Intervention: Comet assay (single‐cell gel electrophoresis) for measuring DNA strand breaks
Number of subjects: 0
Study 9329638 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified comet assay with lesion‐specific endonuclease for DNA base oxidation
Number of subjects: 0
Study 8356846 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent CR vaccine (A H1N1 (CR‐125), A H3N2 (CR‐149), and B (CRB‐117))
Number of subjects: 71
Study 8356846 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent CR vaccine (CR‐125 and CR‐149)
Number of subjects: 71
Study 8356846 — intervention group
Group type: EXPERIMENTAL
Intervention: Monovalent CRB‐117
Number of subjects: 71
Study 8356846 — intervention group
Group type: COMPARATOR
Intervention: Inactivated split vaccine
Number of subjects: 71
Study 3437376 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (5 mg orally administered)
Number of subjects: 87
Study 3437376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 2399425 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc/triclosan dentifrice (0.5% zinc citrate and 0.2% triclosan) for 6 months
Number of subjects: 101
Study 2399425 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 101
Study 2399425 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc/triclosan dentifrice (0.5% zinc citrate and 0.2% triclosan)
Number of subjects: 101
Study 1091686 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenylhydantoin (DPH) 100 mg twice daily
Number of subjects: 10
Study 1091686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31424156 — intervention group
Group type: EXPERIMENTAL
Intervention: Dpy19l2-deficient human globozoospermia
Number of subjects: 6
Study 31424156 — intervention group
Group type: COMPARATOR
Intervention: Normozoospermia (control)
Number of subjects: 6
Study 28151878 — intervention group
Group type: EXPERIMENTAL
Intervention: Music playback during stepping-in-place training
Number of subjects: 11
Study 28151878 — intervention group
Group type: COMPARATOR
Intervention: Radio podcast playback during stepping-in-place training
Number of subjects: 11
Study 26141203 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Disease Self‐Management Program
Number of subjects: 91
Study 26141203 — intervention group
Group type: COMPARATOR
Intervention: Wellness standard of care comparison group
Number of subjects: 91
Study 23870717 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay for Performance (P4P) programme
Number of subjects: 1500
Study 23870717 — intervention group
Group type: COMPARATOR
Intervention: Current practice
Number of subjects: 1500
Study 22258771 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 22258771 — intervention group
Group type: COMPARATOR
Intervention: Midazolam/Ketamine
Number of subjects: 60
Study 19333103 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician readings
Number of subjects: 396
Study 19333103 — intervention group
Group type: COMPARATOR
Intervention: Radiologist readings
Number of subjects: 396
Study 16502156 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided fantasy present
Number of subjects: 215
Study 16502156 — intervention group
Group type: COMPARATOR
Intervention: Guided fantasy absent
Number of subjects: 215
Study 16502156 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure duration
Number of subjects: 215
Study 15553010 — intervention group
Group type: COMPARATOR
Intervention: Protocol A (fixed injection rate of 2.0 mL/sec with a 70 sec delay)
Number of subjects: 60
Study 15553010 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (80% of contrast in 40 sec, remaining 20% in 20 sec with an 80 sec delay)
Number of subjects: 60
Study 10943748 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep peroneal nerve stimulation
Number of subjects: 10
Study 9398090 — intervention group
Group type: EXPERIMENTAL
Intervention: Epicardial implantable cardioverter defibrillator (ICD)
Number of subjects: 900
Study 9398090 — intervention group
Group type: COMPARATOR
Intervention: No antiarrhythmic treatment (Control)
Number of subjects: 900
Study 8417877 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (300 mg sustained-release, four doses at 12-hour intervals)
Number of subjects: 10
Study 8417877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3091717 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg b.i.d.)
Number of subjects: 100
Study 3091717 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) (1 g t.i.d.)
Number of subjects: 100
Study 3091717 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 100
Study 3091717 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 100
Study 31667747 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga classes (12 weekly sessions)
Number of subjects: 320
Study 31667747 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT) sessions (1-on-1)
Number of subjects: 320
Study 31667747 — intervention group
Group type: COMPARATOR
Intervention: Pain improvement (≥30% at 6 weeks)
Number of subjects: 320
Study 31667747 — intervention group
Group type: COMPARATOR
Intervention: Physical function improvement (≥30% at 6 weeks)
Number of subjects: 320
Study 29763832 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular pain assessment using the Doloplus-2 scale twice a week for 12 weeks
Number of subjects: 112
Study 29763832 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 112
Study 27175574 — intervention group
Group type: EXPERIMENTAL
Intervention: website-tailored
Number of subjects: 235
Study 27175574 — intervention group
Group type: COMPARATOR
Intervention: website-unstructured
Number of subjects: 235
Study 25759402 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg
Number of subjects: 46
Study 25759402 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 400 mg
Number of subjects: 46
Study 25759402 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (both doses)
Number of subjects: 46
Study 25759402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 23006505 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training (3 days/week for 30 min at 65-85% of peak oxygen uptake for aerobic; 2 days/week for resistance training with 9 exercises at 12-repetition-maximum)
Number of subjects: 25
Study 23006505 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training
Number of subjects: 25
Study 21074284 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurt
Number of subjects: 36
Study 21074284 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheese
Number of subjects: 36
Study 21074284 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsules
Number of subjects: 36
Study 21074284 — intervention group
Group type: COMPARATOR
Intervention: Yoghurt and Cheese
Number of subjects: 36
Study 21074284 — intervention group
Group type: COMPARATOR
Intervention: All product groups
Number of subjects: 36
Study 21074284 — intervention group
Group type: EXPERIMENTAL
Intervention: P. freudenreichii subsp. shermanii JS and B. animalis subsp. lactis Bb12
Number of subjects: 36
Study 19213349 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanjie Zhentong Capsule (SJC)
Number of subjects: 58
Study 19213349 — intervention group
Group type: COMPARATOR
Intervention: Temporization (Control)
Number of subjects: 58
Study 16641447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren-pivoxil 200 mg twice daily for 5 days
Number of subjects: 541
Study 16641447 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime-axetil 250 mg twice daily for 10 days
Number of subjects: 541
Study 16641447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren-pivoxil
Number of subjects: 541
Study 16641447 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime-axetil
Number of subjects: 541
Study 11959766 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml 0.5% bupivacaine
Number of subjects: 68
Study 11959766 — intervention group
Group type: COMPARATOR
Intervention: 5 ml 0.9% saline
Number of subjects: 68
Study 9585794 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 to 40 mg/day) + Moclobemide (up to 600 mg/day)
Number of subjects: 18
Study 9585794 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 to 40 mg/day)
Number of subjects: 18
Study 8537616 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention, details not specified
Number of subjects: 0
Study 8537616 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 2295949 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow milk
Number of subjects: 52
Study 2295949 — intervention group
Group type: COMPARATOR
Intervention: Milk-based formula
Number of subjects: 52
Study 85322 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy (CHOP + BCG)
Number of subjects: 669
Study 85322 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (CHOP + bleomycin or COP + bleomycin)
Number of subjects: 669
Study 85322 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance BCG
Number of subjects: 669
Study 85322 — intervention group
Group type: COMPARATOR
Intervention: No further therapy
Number of subjects: 669
Study 30935257 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% lotion
Number of subjects: 1640
Study 30935257 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 1640
Study 31208435 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight bearing functional exercise
Number of subjects: 128
Study 31208435 — intervention group
Group type: COMPARATOR
Intervention: Non-weight bearing quadriceps strengthening exercise
Number of subjects: 128
Study 30355790 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous treatment with bemiparin 3500 IU/0.2 mL/day
Number of subjects: 0
Study 30355790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27096869 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (MIE, 60% VO2MAX)
Number of subjects: 15
Study 27096869 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HIE, 85% VO2MAX)
Number of subjects: 15
Study 24702571 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine plus dexmedetomidine administration (Phase M+D)
Number of subjects: 0
Study 24702571 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine administration (Phase M)
Number of subjects: 0
Study 21621958 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial screws used in tibial baseplate fixation
Number of subjects: 154
Study 21621958 — intervention group
Group type: COMPARATOR
Intervention: Screwless tibial baseplate fixation
Number of subjects: 154
Study 20639797 — intervention group
Group type: COMPARATOR
Intervention: Abdominoplasty without quilting sutures (Group A)
Number of subjects: 58
Study 20639797 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominoplasty with quilting sutures (Group B)
Number of subjects: 58
Study 20639797 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoabdominoplasty (Group C)
Number of subjects: 58
Study 17666461 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management course
Number of subjects: 196
Study 17666461 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical treatment
Number of subjects: 196
Study 17666461 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of intensive medical treatment and self-management course
Number of subjects: 196
Study 15723977 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus‐eluting stents
Number of subjects: 238